Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Methoxy polyethylene glycol epoetin beta

Methoxy polyethylene glycol epoetin beta

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Methoxy polyethylene glycol epoetin beta

42 trials tracked of Methoxy polyethylene glycol epoetin beta: 33 in phase 3 or 4.

42Trials tracked
33Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 8 Phase 3 25 Phase 2 5 Other / NA 4
  1. Phase 4 A Study of Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on Dialysis Completed
  2. Phase 4 A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs) Completed
  3. Phase 4 A Study of Monthly Subcutaneous or Intravenous Mircera in Dialysis Patients With Chronic Renal Anaemia Completed
  4. Phase 4 A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia Completed
  5. Phase 4 A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia Completed
  6. Phase 4 A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis Completed
Show 36 more trials
  1. Phase 4 A Study of Two-Weekly Intravenous Mircera for the Treatment of Dialysis Patients With Chronic Renal Anemia Not Receiving ESA Therapy. Completed
  2. Phase 4 A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. Completed
  3. Phase 3 A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. Completed
  4. Phase 3 LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. Completed
  5. Phase 3 A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia Completed
  6. Phase 3 A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients Completed
  7. Phase 3 A Study Comparing Subcutaneous Mircera and Darbepoetin Alfa for Maintenance Treatment of Anemia in Kidney Transplant Recipients. Completed
  8. Phase 3 A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA. Completed
  9. Phase 3 A Study of Monthly Subcutaneous Continuous Erythropoietin Receptor Activator (CERA) in Predialysis Participants With Chronic Renal Anemia Completed
  10. Phase 3 A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia. Completed
  11. Phase 3 A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients. Completed
  12. Phase 3 A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia Completed
  13. Phase 3 A Study of Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal Anemia Completed
  14. Phase 3 A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. Completed
  15. Phase 3 MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia Completed
  16. Phase 3 A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia Completed
  17. Phase 3 A Study of Intravenous Mircera in Participants With Chronic Renal Anemia Who Are on Dialysis Completed
  18. Phase 3 A Study of Monthly Intravenous C.E.R.A. (Mircera) in Hemodialysis Participants With Chronic Renal Anemia Completed
  19. Phase 3 A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis Completed
  20. Phase 3 A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia Completed
  21. Phase 3 STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients Completed
  22. Phase 3 A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. Completed
  23. Phase 3 A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis Completed
  24. Phase 3 A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis Completed
  25. Phase 3 A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients. Completed
  26. Phase 3 A Study of Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis. Completed
  27. Phase 3 A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. Completed
  28. Phase 2 A Study of Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA) Completed
  29. Phase 2 A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia Completed
  30. Phase 2 Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis Completed
  31. Phase 2 A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. Completed
  32. Phase 2 A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis. Completed
  33. N/A Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis Completed
  34. N/A An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Stage V Chronic Kidney Disease Participants on Hemodialysis Completed
  35. N/A An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD) Completed
  36. N/A An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Chronic Kidney Disease Participants on Dialysis Completed

Showing the 42 most-cited and recently-updated of 42 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.